Results 1 to 10 of about 6,652 (162)

Nano-Cilostazol Mitigates Cisplatin-Induced Nephrotoxicity in Rats via Modulation of Oxidative Stress, Apoptosis, Pyroptosis, and miRNA-155 Signaling [PDF]

open access: yesAntioxidants
Background: This study investigated the renoprotective potential of Nano-Cilostazol against cisplatin (CIS)-induced renal injury in male rats and explored its molecular mechanisms.
Hebatallah M. Saad   +10 more
doaj   +2 more sources

β-aminopropionitrile-induced thoracic aortopathy is refractory to cilostazol and sildenafil in mice. [PDF]

open access: yesPLoS ONE
Thoracic aortopathies are life-threatening diseases including aneurysm, dissection, and rupture. Cilostazol, a phosphodiesterase (PDE) 3 inhibitor, and sildenafil, a PDE5 inhibitor, have been used clinically for peripheral arterial disease and erectile ...
Samuel C Tyagi   +7 more
doaj   +2 more sources

Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis. [PDF]

open access: yesPLoS ONE
BackgroundCilostazol has been shown to improve walking distance in patients with lower extremity arterial disease (LEAD) and may reduce restenosis after revascularization.
Hsien-Yuan Chang   +5 more
doaj   +2 more sources

Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease [PDF]

open access: yesEndocrinology and Metabolism, 2022
Background The role of aspirin in primary cardiovascular disease prevention in patients with diabetes remains controversial. However, some studies have suggested beneficial effects of cilostazol on cardiovascular disease in patients with diabetes.
Sangmo Hong   +2 more
doaj   +1 more source

Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis.

open access: yesPLoS ONE, 2022
ObjectiveTo evaluate the efficacy and safety of cilostazol, pentoxifylline, beraprost for intermittent claudication due to lower extremity arterial occlusive disease.MethodsRandomized controlled clinical trials were identified from PubMed, Scopus, EMbase,
Xinyu Liang   +3 more
doaj   +2 more sources

Physical Characteristics of Cilostazol–Hydroxybenzoic Acid Cocrystals Prepared Using a Spray Drying Method

open access: yesCrystals, 2020
The cocrystal formation of pharmaceuticals can improve the various physical properties of drugs, such as solubility, without the need for chemical modification of the drug substances.
Maho Urano   +6 more
doaj   +1 more source

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model

open access: yesBrazilian Journal of Cardiovascular Surgery, 2021
Introduction: To clarify the potential protective role of cilostazol on rat myocardial cells with ischemia-reperfusion injury (IRI) models. Methods: The study was conducted with three groups of 10 Wistar rats (control group, rats without any coronary ...
Mazlum Sahin   +2 more
doaj   +1 more source

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study.

open access: yesPLoS ONE, 2022
PurposeDrug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions.
Takashi Miura   +10 more
doaj   +1 more source

Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells. [PDF]

open access: yesPLoS ONE, 2016
A neuroprotective role of autophagy mediates the degradation of β-amyloid peptide (Aβ) in Alzheimer's disease (AD). The previous study showed cilostazol modulates autophagy by increasing beclin1, Atg5 and LC3-II expressions, and depletes intracellular Aβ
So Youn Park   +6 more
doaj   +1 more source

Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits. [PDF]

open access: yesPLoS ONE, 2012
Cilostazol is clinically used for the treatment of ischemic symptoms in patients with chronic peripheral arterial obstruction and for the secondary prevention of brain infarction.
Hideki Ito   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy